Research Article
Assessment of the Implementation of Critical Pathway in Stroke Patients: A 10-Year Follow-Up Study
Table 2
Comparison of preexisting medical conditions of stroke patients before and after CP implementation.
| | Before () | After () | value |
| Hypertension | 70 (70.0%) | 640 (74.4%) | 0.405 | Alcohol abuse | 38 (38.0%) | 365 (42.4%) | 0.456 | Diabetes mellitus | 33 (33.0%) | 236 (27.4%) | 0.292 | Smoking | 31 (31.0%) | 221 (25.7%) | 0.307 | Cardiac arrhythmia | 28 (28.0%) | 144 (16.7%) | 0.008 | Osteoarthritis | 25 (25.0%) | 221 (25.7%) | 0.976 | Dyslipidemia | 25 (25.0%) | 104 (12.1%) | 0.001 | Previous stroke | 20 (20.0%) | 145 (16.9%) | 0.517 | Coronary artery disease | 12 (12.0%) | 76 (8.8%) | 0.393 | Valvular heart disease | 6 (6.0%) | 76 (8.8%) | 0.440 | Renal failure | 5 (5.0%) | 34 (4.0%) | 0.815 | COPD/asthma | 4 (4.0%) | 34 (4.0%) | 1.000 | Deep vein thrombosis | 2 (2.0%) | 41 (4.8%) | 0.312 | Hydrocephalus | 2 (2.0%) | 9 (1.0%) | 0.725 | Seizure history | 0 (0.0%) | 6 (0.7%) | 0.867 |
|
|
Values are presented as the number (%). CP: critical pathway; COPD: chronic obstructive pulmonary disease. , , and . |